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Background: Reperfusion after resuscitation from cardiac arrest (CA) is an event that increases reactive oxygen
species production leading to oxidative stress. More specifically, myocardial oxidative stress may play a role in the
severity of post-CA myocardial dysfunction. This study investigated the relationship between myocardial oxidative
stress and post-CA myocardial injury and dysfunction in a rat model of CA and cardiopulmonary resuscitation
(CPR). Ventricular fibrillation was induced in 26 rats and was untreated for 6 min. CPR, including mechanical chest
compression, ventilation, and epinephrine, was then initiated and continued for additional 6 min prior to
defibrillations. Resuscitated animals were sacrificed at two h (n = 9), 4 h (n = 6) and 72 h (n = 8) following resuscitation,
and plasma collected for assessment of: high sensitivity cardiac troponin T (hs-cTnT), as marker of myocardial injury;
isoprostanes (IsoP), as marker of lipid peroxidation; and 8-hydroxyguanosine (8-OHG), as marker of DNA oxidative
damage. Hearts were also harvested for measurement of tissue IsoP and 8-OHG. Myocardial function was assessed
by echocardiography at the corresponding time points. Additional 8 rats were not subjected to CA and served as
baseline controls.
Results: Compared to baseline, left ventricular ejection fraction (LVEF) was reduced at 2 and 4 h following
resuscitation (p < 0.01), while it was similar at 72 h. Inversely, plasma hs-cTnT increased, compared to baseline, at 2
and 4 h post-CA (p < 0.01), and then recovered at 72 h. Similarly, plasma and myocardial tissue IsoP and 8-OHG
levels increased at 2 and 4 h post-resuscitation (p < 0.01 vs. baseline), while returned to baseline 72 h later.
Myocardial IsoP were directly related to hs-cTnT levels (r = 0.760, p < 0.01) and inversely related to LVEF (r = -0.770,
p < 0.01). Myocardial 8-OHG were also directly related to hs-cTnT levels (r = 0.409, p < 0.05) and inversely related to
LVEF (r = -0.548, p < 0.01).
Conclusions: The present study provides evidence that lipid peroxidation and DNA oxidative damage in
myocardial tissue are closely related to myocardial injury and LV dysfunction during the initial hours following CA.
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The prognosis of cardiac arrest after cardiopulmonary
resuscitation (CPR) remains poor, with more than 70%
of resuscitated patients dying within 72 h after return of
spontaneous circulation (ROSC), due to the well described
post-cardiac arrest syndrome [1]. Severe heart contractile
failure due to post-resuscitation myocardial dysfunction
has been implicated as the most important mechanism
accounting for early death after ROSC [2].
Due to the complexity and interplay of events occur-
ring during cardiac arrest and after ROSC, mechanisms
involved in post-resuscitation myocardial dysfunction
are not completely understood, and new injury pathways
have been described [3]. Cardiac arrest is a global ische-
mic event followed by a whole body reperfusion when
ROSC is achieved. Indeed, ischemia-reperfusion (I/R) is
a process characterized by reactive oxygen species (ROS)
generation, which starts during ischemia and is further
exacerbated by defibrillation attempts and subsequently
by return of oxygenated blood to the tissues after ROSC
[4-6]. This increase in ROS production leads to oxida-
tion of cell macromolecules, such as lipids, proteins, and
possibly DNA, in a process overall named oxidative
stress [7,8]. The oxidative stress events are recognized to
participate in processes leading to acute inflammatory
response, cell damage, mitochondrial dysfunction, de-
crease in nitric oxide (NO) availability, and ultimately
cell apoptosis and death [4-7,9-12]. In the heart, these
events may impair the normal function of cardiomyo-
cytes, contributing to the severity of post-cardiac arrest
myocardial dysfunction [4].
There are no published studies comprehensively asses-
sing the relations over time between different markers of
oxidative stress in plasma and myocardium, cardiac tro-
ponins (cTn) and left ventricular (LV) function. The aim
of this study was to investigate the severity of myocardial
oxidative stress following resuscitation in a rat model of
cardiac arrest and CPR and its relationship with the sever-
ity of post-cardiac arrest myocardial injury and dysfunc-
tion. We hypothesized that myocardial oxidative injury
may contribute to the severity of post-cardiac arrest myo-
cardial injury and dysfunction.Methods
Procedures involving animals and their care were in
compliance with national (D.L. n. 116, G.U., suppl. 40,
18 February 1992, Circolare no. 8, G.U., 14 Luglio 1994)
and international laws and policies (EEC Council Direct-
ive 86/609, OJL 358, 1, December 12, 1987; Guide for
the Care and Use of Laboratory Animals, US National
Research Council, 1996). Approvals of the studies were
obtained by the local institutional review board committee
and governmental institution.Animal preparation
Thirty-four male Sprague-Dawley rats weighing 470 ± 26 g
were fasted overnight except for free access to water. The
details of the animal preparation were published previ-
ously [3]. In brief, the animals were anesthetized by in-
traperitoneal injection of pentobarbital (50 mg/kg), and
additional doses (10 mg/kg) were administrated at inter-
vals of approximately 1 h or when required to maintain
anesthesia. The trachea was orally intubated with a 14-
gauge cannula. A PE-50 catheter (Becton Dickinson,
FranklinLakes, NJ) was advanced into the descending
aorta from the left femoral artery for measurement of
arterial pressure and sampling arterial blood. Through
the left external jugular vein, another PE-50 catheter
was advanced into the right atrium for measurement of
right atrial pressures. Aortic and right atrial pressures
were measured with reference to the mid chest with
high-sensitivity transducers. A 3-F PE catheter (model
C-PMS-301 J, Cook Critical Care, Bloomington, IN)
was advanced through the right external jugular vein
into the right atrium. A pre-curved guide wire supplied
with the catheter was then advanced through the catheter
into the right ventricle and confirmed by endocardial elec-
trocardiogram for inducing ventricular fibrillation (VF).
All of the catheters were flushed intermittently with saline
containing 2.5 IU/mL of bovine heparin. A conventional
lead II electrocardiogram (ECG) was continuously mon-
itored. Temperature was continuously monitored with
the aid of a rectal probe and maintained at 37 ± 0.5°C
throughout the experiment.
Experimental procedures
Fifteen minutes prior to inducing VF, baseline measure-
ments were obtained and mechanical ventilation was ini-
tiated with an inspired FiO2 of 0.21. VF was electrically
induced with progressive increases in 60-Hz current to a
maximum of 4 mA delivered to the right ventricular
endocardium. The current flow was continued for 3 min
to prevent spontaneous defibrillation. Mechanical venti-
lation was stopped after the onset of VF. Precordial
compression was begun after 6 min of untreated VF with
a pneumatically driven mechanical chest compressor as
previously described [3]. Coincident with the start of
precordial compression, animals were mechanically venti-
lated at a frequency of 50/min with a tidal volume 0.6 ml/
100 g and a FiO2 of 1.0. Precordial compression was main-
tained at a rate of 200/min with equal compression-
relaxation duration (i.e., 50% duty cycle) and a depth of
compression equal to 25% of the animal’s antero-posterior
chest diameter. Epinephrine (0.02 mg/kg) was injected
into the right atrium 2 min after the start of precordial
compression. After 6 min of CPR, resuscitation was
attempted with up to three 2 Joule defibrillations
(CodeMaster XL, Philips Heartstream, Seattle, WA).
Table 1 Resuscitation outcome
Baseline PR 2 h PR 4 h PR 72 h
(n = 8) (n = 9) (n = 6) (n = 8)
Body Weight, g 475 ± 13 477 ± 7 472 ± 7 458 ± 6
Defibrillations to ROSC, n — 4 ± 1 3 ± 1 2 ± 1
Time to ROSC, sec — 396 ± 16 373 ± 10 360 ± 1
PR, post resuscitation; ROSC, return of spontaneous circulation.
Data shown as mean ± SEM.
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supraventricular rhythm with a mean aortic pressure
(MAP) > 50 mm Hg for a minimum of 5 min. Following
resuscitation, animals were monitored for 4 h. All the
catheters and the endotracheal tubes were then re-
moved. The animals were returned to their cages and
were observed for up to 3 days after resuscitation. Ani-
mals were sacrificed with an intraperitoneal injection
of pentobarbital sodium (150 mg/kg) at different intervals:
baseline, before cardiac arrest; 2 h post-resuscitation; 4 h
post-resuscitation; and 72 h post-resuscitation. Plasma
was withdrawn for biochemical analyses. Blood was
collected into EDTA-tubes and centrifuged for 15 min
at 3000 rpm at 4°C. Plasma samples were then stored
at -80°C. The heart was quickly removed from the thor-
acic cavity, blotted and frozen at -80°C for further
biochemistry.
Measurements
Aortic and right atrial pressures, and ECG were con-
tinuously recorded on a personal computer-based data
acquisition system supported by CODAS hardware and
software (DataQ, Akron, OH). Coronary perfusion pres-
sure (CPP) was calculated as the difference between
aortic and time-coincident right atrial pressures [3].
Transthoracic echocardiography was performed at 3 and
72 h after resuscitation using SSD-5500 echo machine
(Aloka, Tokyo, Japan) equipped with a 13 MHz linear
array transducer at high frame rate imaging (102 Hz) and
a 7.5 MHz phased array probe for pulsed-wave, color and
tissue Doppler imaging. Echocardiographic images were
obtained from parasternal short and long-axis views and
from apical views. End-diastolic and end-systolic wall
thicknesses, systolic wall thickening, LV internal di-
mensions and fractional shortening were measured and
calculated. LV volumes and ejection fraction (EF) were
calculated by the modified single plane Simpson’s rule
from the parasternal long-axis view as previously re-
ported [3]. Aortic outflow velocities were measured
from a 5 apical chamber view by pulsed-wave Doppler
and LV cardiac output (CO) and stroke volume (SV)
were calculated [3].
Plasma high sensitivity cTnT (hs-cTnT) levels were
assessed with an electrochemiluminescence assay (ECLIA,
Elecsys 2010 analyzer, Roche Diagnostics, Germany). Iso-
prostanes (IsoP) and 8-hydroxyguanosine (8-OHG) were
assessed by commercially available ELISA Kits (Cayman
Chemical, Ann Arbor, MI, USA) according to the manu-
facturer’s instruction. Plasma glutathione S-transferase
(GSH) was measured by a spectrophotometric assay, in ac-
cordance with the method of Hu, as previously reported
[13]. Briefly, the method was based on the reaction of thiol
groups with 2,2-dithio-bis-nitrobenzoic acid (DTNB) in
absolute ethanol to give a colored compound absorbing atλ = 412 nm. Removal of proteins was performed with an
excess of absolute ethanol, followed by centrifugation at
3000 g for 10 min at room temperature. Asymmetric
dimethylarginine (ADMA) concentration was also mea-
sured by a commercially available ELISA Kit (DLD
Diagnostika, Hamburg, Germany). For assessment of
dimethylarginine dimethylaminohydrolase (DDAH), tis-
sues were homogenized in 0.1 M phosphate buffer,
pH 6.5, containing 2 mM mercapto-ethanol and prote-
ase inhibitor cocktail (1:1000). Homogenates were cen-
trifuged at 5000 g for 60 min, and supernatants were
collected for DDAH enzyme activity assay. DDAH en-
zyme activity was assayed by determining L-citrulline
formation in a 96-well microtiter plate. One unit of en-
zyme activity was defined as the amount of enzyme
catalyzing the formation of 1 mol L-citrulline/min at
37°C.
Statistical analysis
One sample Kolmogorov–Smirnov Z test was used to
confirm normal distribution of the data. Comparisons
among time-based measurements within groups were
performed by one-way ANOVA with Fisher’s LSD post-
hoc test. Linear correlations between parametric variables
were calculated using the Pearson correlation coefficient.
Spearman test was performed for the non-parametric
variable correlation analyses. Data are reported as
mean ± SEM, except for hs-cTnT, presented as median
[25-75 percentile]. A 2-tail p < 0.05 was considered as
statistically significant. The analyses were performed
using GraphPad Prism 6.
Results
A total of 34 rats were included in the study. Eight con-
trol rats were not subjected to cardiac arrest and served
as baseline, while the other 26 underwent cardiac arrest
and CPR. Among the 26 cardiac arrest rats, 23 were suc-
cessfully resuscitated (88%) and were assigned to be
sacrificed at 2 h (n = 8), 4 h (n = 9), and 72 h (n = 8) after
resuscitation. No differences in body weight and number
of defibrillations and duration of CPR prior to ROSC
were observed among the groups (Table 1). Among the
8 rats undergoing to 72 h of post-resuscitation observa-
tion, 5 (63%) survived till the end of the observational
period.
Figure 2 Myocardial function. Left ventricle stroke volume (SV),
cardiac output (CO) and ejection fraction (EF) at baseline (BL) and
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Each rat developed a marked post-resuscitation myocar-
dial dysfunction during the 4 h of observation, which
regressed 72 h later. Indeed, heart rate was significantly
reduced during the first 2 h post-resuscitation compared
to baseline (Figure 1), while MAP and CPP remained de-
creased for the entire 4 h post-resuscitation (p < 0.01 vs.
baseline, Figure 1). Similarly to hemodynamics, LV end
systolic volume and EF were also significantly decreased
at 2 and 4 h post-resuscitation (p < 0.01 vs. baseline), while
returned to baseline 72 h later (Figure 2). Resuscitated rats
also presented markedly reduced LV SV and CO (p < 0.01
vs. baseline, Figure 2) at 2, 4, and 72 h post-resuscitation.
Changes observed in post-resuscitation myocardial
function, expressed as LVEF, were paralleled by the con-
current changes in circulating levels of hs-cTnT (Table 2).
Plasma levels of hs-cTnT, in fact, significantly increased at
2 and 4 h post-resuscitation (p < 0.01 vs. baseline), and
then normalized at 72 h (Table 2). Hs-cTnT levels in-
versely correlated with LVEF (r = -0.89, p < 0.01).
Oxidative stress biomarkers
Plasma levels of IsoP, a marker of lipid peroxidation, sig-
nificantly increased at 4 h post-resuscitation and recov-
ered 72 h later (p < 0.05 vs. baseline, Table 2). Changes
in myocardial tissue IsoP were more evident comparedFigure 1 Hemodynamics. Heart rate (HR), mean arterial pressure
(MAP) and coronary perfusion pressure (CPP) at baseline (BL) and
post-resuscitation. Data are shown as mean ± SEM; *p < 0.05 and
**p < 0.01 vs. BL.
post-resuscitation (PR). The bottom table reports data on left
ventricle end systolic volume (ESV) and end diastolic volume (EDV).
Data are shown as mean ± SEM; *p < 0.05 and **p < 0.01 vs. BL.to those in plasma (Figure 3). Myocardial IsoP markedly
increased at 2 and 4 h post-resuscitation (p < 0.01 vs.
baseline, Figure 3), while levels returned to baseline
values 72 h later. Myocardial IsoP were directly related
to plasma hs-cTnT (r = 0.760, p < 0.0001, Figure 3) and
inversely related to LV EF (r = -0.770, p < 0.0001,
Figure 3).
Plasma levels of 8-OHG, a marker of DNA damage,
significantly increased at 2 h post-resuscitation and re-
covered within the following 2 h of observation (p < 0.05
vs. baseline, Table 2). Changes in myocardial tissue 8-
OHG were more evident compared to those in plasma
(Figure 4). Myocardial 8-OHG markedly increased at 2
and 4 h post-resuscitation (p < 0.01 vs. baseline, Figure 4),
while levels returned to baseline values 72 h later. Myo-
cardial 8-OHG were directly related to plasma hs-cTnT
(r = 0.409, p < 0.05, Figure 4) and inversely related to
LVEF (r = -0.548, p < 0.01, Figure 4).
Plasma levels of GSH slightly decreased at 2 and 4 h
post-resuscitation (p not significant) and recovered 72 h
later (Table 2).
ADMA, an endogenous inhibitor of nitric oxide syn-
thase (NOS), was assayed in plasma and myocardial tissue.
Plasma levels of ADMA were significantly decreased at
Table 2 Circulating oxidative stress biomarkers and asymmetrical dimethylarginine (ADMA) and dimethylarginine
dimethylaminohydrolase (DDAH)
Baseline PR 2 h PR 4 h PR 72 h
(n = 8) (n = 9) (n = 6) (n = 8)
Plasma hs-cTnT, ng/L 61 [20-91] 3732 [3277-6218]** 3469 [2428-4930]* 44 [39-1610]
Plasma IsoP, pg/mL 235.6 ± 28.8 206.2 ± 14.9 306.6 ± 21.6* 216.6 ± 30.0
Plasma 8-OHG, pg/mL 742.9 ± 79.3 1044.5 ± 71.1* 914.9 ± 104.1 846.9 ± 14.7
Plasma GSH, μmol/mL 0.146 ± 0.030 0.099 ± 0.004 0.095 ± 0.013 0.136 ± 0.023
Plasma ADMA, μmol/L 0.767 ± 0.10 0.641 ± 0.07 0.468 ± 0.06* 0.601 ± 0.07
Myocardial ADMA, nmol/mg prot 0.083 ± 0.01 0.052 ± 0.01 0.043 ± 0.01 0.080 ± 0.02
Myocardial DDAH, nmol/mg prot 77.5 ± 12.7 73.5 ± 7.2 79.0 ± 10.4 90.0 ± 12.8
PR, post resuscitation; 8-OHG, 8-hydroxyguanosine; hs-cTnT, high-sensitivity cardiac troponin T; IsoP, isoprostanes; GSH, glutathione S-transferase.
Parametric data are shown as mean ± SEM; Non-parametric data are shown as median [25-75 percentile].
*p < 0.05 vs. Baseline; **p < 0.01 vs. Baseline.
Figure 3 Myocardial isoprostanes vs. myocardial injury and
function. Upper: Myocardial isoprostanes (IsoP) levels at baseline
(BL) and post resuscitation (PR), reported as mean ± SEM,
**p < 0.01 vs. BL. Bottom: relation between IsoP and high-sensitivity
cardiac troponin (hs-cTnT) and left ventricle ejection fraction
(LVEF).
Figure 4 Myocardial 8-hydroxyguanosine vs. myocardial injury
and function. Upper: Myocardial 8-hydroxyguanosine (8-OHG) levels
at baseline (BL) and post resuscitation (PR), reported as mean ± SEM,
**p < 0.01 and *p < 0.05 vs. BL. Bottom: relation between 8-OHG and
high-sensitivity cardiac troponin (hs-cTnT) and left ventricle ejection
fraction (EF).
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Table 2). Similarly, there was a trend towards decreases in
myocardial ADMA levels during the 4 h of post-
resuscitation (p = 0.05 vs. baseline, Table 2), while it recov-
ered to baseline values 72 h later.
Decreases in myocardial ADMA were paralleled by
concurrent changes in myocardial DDAH, the enzyme
that degrades ADMA (Table 2). However, only a trend
towards increases in myocardial DDAH was observed at
4 and 72 h post-resuscitation (p not significant, Table 2).
Discussion
The present study describes the entity of circulating and
myocardial tissue levels of oxidative stress markers dur-
ing the initial hours post-resuscitation and it suggests a
contribution of oxidative damage to the severity of post-
cardiac arrest myocardial injury and dysfunction. Indeed,
IsoP and 8-OHG levels in the myocardial tissue signifi-
cantly increased at 2 and 4 h post-resuscitation, and
these increases related to the increased hs-cTnT levels, a
specific marker of myocardial injury, and to the impaired
LVEF, a marker of myocardial dysfunction. Plasma levels
of circulating IsoP and 8-OHG were also significantly
increased after resuscitation, indicating a concurrent con-
dition of whole body oxidative stress.
Post-cardiac arrest myocardial dysfunction contributes
to the early deaths after resuscitation from cardiac arrest
[2]. It is characterized by a compromised LV systolic
function with low CO and arterial pressure. In patients
who survive, this myocardial dysfunction is transient and
fully recovers during the following 2-3 days after ROSC
[2]. cTn are regulatory proteins belonging to the heart’s
contractile apparatus that regulates the calcium-mediated
interaction of actin and myosin. Accordingly, cTn release
is commonly observed after resuscitation from cardiac
arrest [14]. The release of cTn from the myocardium
might reflect an ongoing myocyte cell death as well as
other events, i.e. myocyte stretching with transient loss
of cell membrane integrity, and is related to the severity
of myocardial dysfunction [14,15]. In our study, we ob-
served significant reductions in post-cardiac arrest LV
EF, at 2 and 4 h following ROSC, with a subsequent re-
covery 72 h later. A strong relationship between LV EF
and circulating hs-cTnT was confirmed at different time
points following ROSC. Normal LV function at 72 h
post ROSC indicates that myocardial viability was pre-
served even in the presence of previous hs-cTnT degrad-
ation. This suggests that post-resuscitation myocardial
dysfunction is largely reversible in the present model.
ROS formation, including free radical superoxide,
hydrogen peroxide, and hydroxyl radical, occurs in low
levels under physiological conditions, but it is exacer-
bated as a consequence of I/R injury [5-8]. Under this
condition of I/R, ROS are produced in myocardial andother tissues by several mechanisms, involving actions of
xanthine oxidase, NOS, and nicotinamide adenine di-
nucleotide phosphate oxidase [16,17,3]. Consequently,
this exacerbated ROS production creates an imbalance
between oxidant and antioxidant mechanisms inside the
cells, which may contribute to post-cardiac arrest myo-
cardial dysfunction [18]. Inflammatory cell infiltration in
myocardial tissue is another well known process after I/R
that contributes to ROS generation, leading to apoptosis
of cardiomyocytes [4]. Finally, mitochondria play also a
crucial role in increasing ROS generation after I/R, due
to an uncoupling of electron transport chain after reper-
fusion [19]. The consequent ROS increase in the mito-
chondria, in addition to the reperfusion-related calcium
overload, further activates the apoptotic cell death path-
ways [20,21]. Indeed, earlier studies have reported that
mitigating ROS production, by limiting myocardial in-
jury, may represent a future target for new therapeutic
interventions [4]. Indeed, a recent experimental study
confirmed that administration of an antioxidant after
ROSC, i.e. ascorbic acid, was able to reduce lipid per-
oxidation, resulting in an improved post-resuscitation
myocardial dysfunction and ultimately in a greater
survival [12].
In our study we assessed oxidative stress after CPR by
measuring markers of lipid oxidation, namely IsoP, and a
marker of DNA oxidation, namely 8-OHG. IsoP are stable
products of arachidonic acid oxidation and are released
from cells undergoing oxidative stress [22]. Indeed, two-
to three-fold increases in IsoP have been previously re-
ported in plasma after resuscitation from cardiac arrest in
pigs, and in cardiac tissue after myocardial I/R in mice
[6,23]. IsoP present important biological activity [7]. The
oxidation of these lipids, in fact, impairs cell membrane
stability, leading to altered permeability, endothelial dys-
function, and consequent cell damage [5,24]. In a model
of myocardial I/R in rats, pretreatment with F-isoprostane
induced a five-fold increased endothelin-1 release, im-
paired LV developed pressure, and increased infarct size
compared to control animals [24]. Indeed, in our experi-
ment, both plasma and myocardial tissue IsoP significantly
increased after resuscitation. Nevertheless, myocardial
IsoP increase was more evident compared to plasma in-
crease and highly correlated with hs-cTnT releases and
LV dysfunction over time.
8-OHG is a specific biomarker of oxidative damage to
DNA [25,26]. Similarly to our results, increases in urin-
ary 8-OHG have been reported in patients with acute
myocardial infarction, with peak levels at 4 h after reper-
fusion therapy and a return to baseline levels within
24 h [27]. Whether oxidative stress-related DNA damage
and altered gene expression may contribute to LV dys-
function and remodeling after an ischemic event is not
clear [28]. A report in a rat model of I/R demonstrated
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perfusion, which, however, seemed not to have any rela-
tion with the altered LV function [9]. Other studies,
instead, reported a correlation between the oxidative
damage to mitochondrial DNA and the severity of LV
dilatation and reduced contractility in mice subjected to
myocardial infarction [28]. Similarly to our results, high
serum and urinary levels of 8-OHG were observed in
patients with heart failure and further increases in 8-
OHG occurred for higher New York Heart Association
(NYHA) functional class, such that 8-OHG was sug-
gested as prognostic tool for risk stratification in these
patients [25,26]. To the best of our knowledge, this is
the first study relating 8-OHG to post-cardiac arrest LV
dysfunction. Our results suggest a relationship between
8-OHG and myocardial injury and function, similarly to
IsoP. Increase in post-resuscitation 8-OHG levels were,
however, of lesser extent compared to those in IsoP.
Oxidative stress following cardiac arrest is a systemic
event, such that oxidative stress biomarkers are generated
in all tissues, as products of the oxidation of molecules
present in every cell types [27,29]. Such a condition of
whole body post-resuscitation oxidative stress is indeed
supported by the significant increases in plasma IsoP and
8-OHG together with the concurrent reduction in plasma
GSH, a known endogenous inactivator of oxygen-derived
highly reactive species [13]. Consequently, in contrast
to plasma levels, dosage of oxidative stress biomarkers
directly in myocardial tissue was a more reliable marker
for myocardial damage, and better represented the time-
dependent oxidative stress in our study. Myocardial IsoP
and 8-OHG increases were directly related with hs-cTnT
and inversely related with LVEF. Whether the observed re-
lation between tissue IsoP and 8-OHG and established
markers of cardiac injury such as cTn and LVEF, is causal
needs to be further investigated.
Accordingly, our findings indicate a possible contribu-
tion of oxidative stress to post-cardiac arrest myocardial
injury and dysfunction. After I/R, endothelial dysfunction
and inhibition of NOS with reduced NO availability are
commonly observed, due to oxidative stress [11]. NO is an
endothelium-derived vasoactive factor produced by NOS,
that plays important roles in modulating coronary vascular
tone and tissue perfusion [30]. NO, however, is also known
to be able to react with free radical superoxide producing
peroxynitrite, a more powerful oxidating reactive specie,
which worsens tissue damage by protein nitration [31].
ADMA is an endogenous inhibitor of NOS activity,
present in high concentration inside the endothelial
cells [32,33]. In a recent study in coronary artery bypass
grafting patients, cardioplegic arrest was associated with
decreased plasma levels of ADMA; the mechanisms in-
volved in this process remained, however, unexplained
[34]. Similarly, in our study, decreases in both plasmaand myocardial tissue levels of ADMA after cardiac ar-
rest were observed and paralleled reductions in LVEF
and increases in hs-cTnT. Decreases in myocardial
ADMA were paralleled and explained by concurrent in-
creases in its degrading enzyme DDAH [33]. It can be
hypothesized that these ADMA decreases may poten-
tially exacerbate post-cardiac arrest myocardial dysfunc-
tion. Decreases in ADMA may, in fact, lead to decrease
in NOS inhibition and consequent greater NO production
and nitrosative stress [35]. Moreover, besides inhibiting
NO synthesis, ADMA can directly induce oxidative stress
and cell apoptosis, and participate in inflammatory reac-
tions [33,34,36,37]. Indeed, by inhibiting endothelial NOS,
ADMA might increase the risk of vascular inflammation
and thrombosis, such that elevated plasma ADMA has
been reported to be a risk factor for cardiovascular mor-
bidity and mortality in patients with cardiovascular disease
[33]. Thus, we cannot exclude that decrease in ADMA
may, instead, reflect an adaptive change aimed to protect
from oxidative stress.
Some limitations need to be taken into account when
interpreting our results. First, the study was performed
in healthy animals with no previous myocardial damage.
Second, this study is a descriptive report and no direct
mechanisms assessing the connection between oxida-
tive stress and myocardial damage and dysfunction
were shown, nor effects from inhibition of oxidative
stress pathways on post-resuscitation myocardial dys-
function. Accordingly, further interventional experi-
mental studies are underway. Nevertheless, the results
demonstrated the clear relationship between oxidative
stress and post-resuscitation hs-cTnT release and LV
dysfunction. Moreover, both circulating and tissue levels
of oxidative stress markers have been reported overtime
post-resuscitation, providing new insights in the time-
course of these biomarkers.
Conclusions
The present study in a rat model of CPR demonstrated
the possible contribution of oxidative damage to post-
cardiac arrest syndrome. It provided evidence that lipid
peroxidation and DNA oxidative damage in myocardial
tissue are closely related to myocardial injury, represented
by hs-cTnT release, and LV dysfunction, represented by
reduced EF, during the initial hours following resuscitation
from cardiac arrest.
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